DexCom Inc. Executive Compensation Details Revealed

Ticker: DXCM · Form: DEF 14A · Filed: 2024-04-22T00:00:00.000Z

Sentiment: neutral

Topics: executive-compensation, proxy-statement, stock-awards

Related Tickers: DXCM

TL;DR

DexCom exec pay details out for 2023 - stock awards, fair values, PEO/Non-PEO breakdown.

AI Summary

DexCom Inc. filed a DEF 14A on April 22, 2024, detailing executive compensation for the fiscal year ending December 31, 2023. The filing includes information on stock awards, year-end fair values of unvested equity awards, and compensation for both PEO (Principal Executive Officer) and Non-PEO members. Specific dollar amounts for these compensation components are detailed within the filing.

Why It Matters

This filing provides transparency into how much top executives at DexCom Inc. are being compensated, which can influence investor perception and corporate governance discussions.

Risk Assessment

Risk Level: low — This is a routine DEF 14A filing providing information on executive compensation, not indicating any immediate financial distress or significant operational changes.

Key Numbers

2023 — Fiscal Year End (Compensation data pertains to this year.)
2022 — Prior Fiscal Year (Comparative compensation data may be available.)
2021 — Prior Fiscal Year (Comparative compensation data may be available.)
2020 — Prior Fiscal Year (Comparative compensation data may be available.)

Key Players & Entities

DexCom Inc. (company) — Filer of the DEF 14A
April 22, 2024 (date) — Filing date of the DEF 14A
December 31, 2023 (date) — Fiscal year end for compensation reporting

FAQ

What were the total stock awards granted to PEO members in 2023?

The filing details deductions for amounts reported under stock awards for PEO members for the period January 1, 2023 to December 31, 2023, but specific total dollar amounts are not provided in this excerpt.

What is the year-end fair value of equity awards granted during 2023 that remained unvested for Non-PEO members?

The filing references 'YearEndFairValueOfEquityAwardsGrantedDuringTheYearThatRemainedUnvestedAsOfTheEndOfTheCoveredYearMember' for Non-PEO members for the period January 1, 2023 to December 31, 2023, but the specific dollar value is not in this excerpt.

When was the DEF 14A filing submitted to the SEC?

The filing was submitted on April 22, 2024.

What is the primary purpose of a DEF 14A filing?

A DEF 14A filing is a definitive proxy statement used to solicit shareholder votes and provides detailed information on matters presented at a shareholder meeting, including executive compensation.

What is DexCom Inc.'s Standard Industrial Classification (SIC) code?

DexCom Inc.'s SIC code is 3841, which corresponds to Surgical & Medical Instruments & Apparatus.

From the Filing

0001093557-24-000070.txt : 20240422 0001093557-24-000070.hdr.sgml : 20240422 20240422163236 ACCESSION NUMBER: 0001093557-24-000070 CONFORMED SUBMISSION TYPE: DEF 14A PUBLIC DOCUMENT COUNT: 52 CONFORMED PERIOD OF REPORT: 20240522 FILED AS OF DATE: 20240422 DATE AS OF CHANGE: 20240422 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DEXCOM INC CENTRAL INDEX KEY: 0001093557 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 330857544 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: DEF 14A SEC ACT: 1934 Act SEC FILE NUMBER: 000-51222 FILM NUMBER: 24861592 BUSINESS ADDRESS: STREET 1: 6340 SEQUENCE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8582000200 MAIL ADDRESS: STREET 1: 6340 SEQUENCE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 DEF 14A 1 dxcm-20240422.htm DEF 14A dxcm-20240422 DEF 14A false 0001093557 0001093557 2023-01-01 2023-12-31 iso4217:USD 0001093557 2022-01-01 2022-12-31 0001093557 2021-01-01 2021-12-31 0001093557 2020-01-01 2020-12-31 0001093557 ecd:PeoMember dxcm:DeductionsForAmountsReportedUnderTheStockAwardsColumnInTheSummaryCompensationTableMember 2023-01-01 2023-12-31 0001093557 ecd:NonPeoNeoMember dxcm:DeductionsForAmountsReportedUnderTheStockAwardsColumnInTheSummaryCompensationTableMember 2023-01-01 2023-12-31 0001093557 dxcm:YearEndFairValueOfEquityAwardsGrantedDuringTheYearThatRemainedUnvestedAsOfTheEndOfTheCoveredYearMember ecd:PeoMember 2023-01-01 2023-12-31 0001093557 dxcm:YearEndFairValueOfEquityAwardsGrantedDuringTheYearThatRemainedUnvestedAsOfTheEndOfTheCoveredYearMember ecd:NonPeoNeoMember 2023-01-01 2023-12-31 0001093557 ecd:PeoMember dxcm:VestingDateFairValueForAwardsGrantedAndVestedInTheSameFiscalYearMember 2023-01-01 2023-12-31 0001093557 ecd:NonPeoNeoMember dxcm:VestingDateFairValueForAwardsGrantedAndVestedInTheSameFiscalYearMember 2023-01-01 2023-12-31 0001093557 dxcm:ChangeInYearEndFairValueOfEquityAwardsGrantedDuringPriorYearsThatRemainedUnvestedAsOfTheEndOfTheCoveredYearMember ecd:PeoMember 2023-01-01 2023-12-31 0001093557 ecd:NonPeoNeoMember dxcm:ChangeInYearEndFairValueOfEquityAwardsGrantedDuringPriorYearsThatRemainedUnvestedAsOfTheEndOfTheCoveredYearMember 2023-01-01 2023-12-31 0001093557 ecd:PeoMember dxcm:ChangeInFairValueFromPriorYearEndToVestingDateForAwardsGrantedInPriorYearsThatVestedInCoveredFiscalYearMember 2023-01-01 2023-12-31 0001093557 ecd:NonPeoNeoMember dxcm:ChangeInFairValueFromPriorYearEndToVestingDateForAwardsGrantedInPriorYearsThatVestedInCoveredFiscalYearMember 2023-01-01 2023-12-31 0001093557 ecd:PeoMember dxcm:PriorYearEndFairValueForAwardsGrantedInPriorYearsThatAreForfeitedDuringTheCoveredYearMember 2023-01-01 2023-12-31 0001093557 ecd:NonPeoNeoMember dxcm:PriorYearEndFairValueForAwardsGrantedInPriorYearsThatAreForfeitedDuringTheCoveredYearMember 2023-01-01 2023-12-31 0001093557 dxcm:NetIncreasesForTheInclusionOfRule402vEquityValuesMember ecd:PeoMember 2023-01-01 2023-12-31 0001093557 dxcm:NetIncreasesForTheInclusionOfRule402vEquityValuesMember ecd:NonPeoNeoMember 2023-01-01 2023-12-31 0001093557 1 2023-01-01 2023-12-31 0001093557 2 2023-01-01 2023-12-31 0001093557 3 2023-01-01 2023-12-31 Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.     ) Filed by the Registrant   ý                              Filed by a party other than the Registrant  ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ý Definitive Proxy Statement ☐ Definitive Additional Materials ☐ Soliciting Material under